Bolt Biotherapeutics, Inc. (BOLT) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $11.70M | +62.4% |
| 2024 | $7.21M | -33.3% |
| 2023 | $10.81M | +16.9% |
| 2022 | $9.24M | -66.2% |
| 2021 | $27.38M | +394.1% |
| 2020 | $5.54M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $11.70M | +62.4% |
| 2024 | $7.21M | -33.3% |
| 2023 | $10.81M | +16.9% |
| 2022 | $9.24M | -66.2% |
| 2021 | $27.38M | +394.1% |
| 2020 | $5.54M | — |